Downey AE

Translational Psychedelic Research Program, Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco.

10 papers · ORCID

ArticlePsilocybin

An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression.

Downey AE, Szigeti B, Bradley ER +11

Europe PMC2026
ArticlePsilocybin

A randomized crossover trial comparing the acute physiological and psychological effects of botanical formulations of oral psilocybin, oral psilocin, and sublingual psilocin.

Tai ML, Szigeti B, Downey AE +12

Europe PMC2026
ArticlePsilocybin

Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care.

Geller JA, Pacilio R, Downey AE +4

Europe PMC2026
ArticlePsilocybin

Sudden Loss of Consciousness Following Psilocybin Ingestion.

Downey AE, Tai ML, Bradley ER +1

Europe PMC2025
ArticlePsychedelics

Leveraging family and caregiver support in psychedelic-assisted therapy: considerations for the treatment of adolescents.

Forsberg S, Downey AE, Bruett LD +5

Europe PMC2025
ArticlePsilocybin

A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.

Haft SL, Downey AE, Raymond-Flesch M +4

Europe PMC2025
ArticlePsilocybin

Innovative and Emerging Treatments for Anorexia Nervosa.

Downey AE, Gorrell S

Europe PMC2024
ArticlePsilocybin

A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?

Downey AE, Bradley ER, Lerche AS +3

Europe PMC2024
ArticlePsilocybin

Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.

Downey AE, Chaphekar AV, Woolley J +1

Europe PMC2024
ArticlePsilocybin

"But the reality is it's happening": A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy.

Downey AE, Boyd M, Chaphekar AV +2

Europe PMC2023